Lanzkowsky's Manual of Pediatric Hematology and Oncology (7th Ed.)
Coordonnateurs : Fish Jonathan D., Lipton Jeffrey M., Lanzkowsky Philip
Lanzkowsky?s Manual of Pediatric Hematology and Oncology, Seventh Edition remains the go-to clinical manual for the treatment and management of childhood cancers and blood disorders. It is a comprehensive book on patient management, replete with algorithms and flow diagrams, and includes a new section on vascular anomalies. Reflecting the considerable advances in the treatment and management of hematologic and oncologic diseases in children, the seventh edition of this successful clinical manual is entirely updated to incorporate all current treatment protocols, new drugs, and management approaches. Its concise and easy-to-read format, again, enables readers to make accurate diagnoses and treatment decisions without having to reference larger medical textbooks.
2. Hematologic manifestations of systemic illness
3. Classification and diagnosis of anemia in children and neonates
4. Nutritional anemias
5. Lymphadenopathy and diseases of the spleen
6. Bone marrow failure
7. General considerations of hemolytic diseases, red cell membrane, and enzyme defects
8. Extracorpuscular hemolytic anemia
9. Hemoglobinopathies
10. Primary and secondary erythrocytosis
11. Disorders of white blood cells
12. Disorders of platelets
13. Disorders of coagulation
14. Vascular anomalies
15. Histiocytic disorders
16. Lymphoproliferative disorders
17. Myelodysplastic syndromes and myeloproliferative disorders
18. Acute lymphoblastic leukemia
19. Acute myeloid leukemia
20. Hodgkin lymphoma
21. Non-Hodgkin lymphoma
22. Central nervous system tumors
23. Neuroblastoma
24. Renal tumors
25. Rhabdomyosarcoma and other soft-tissue sarcomas
26. Malignant bone tumors
27. Retinoblastoma
28. Extracranial germ cell tumors
29. Hepatic tumors
30. Hematopoietic stem cell transplant and cellular therapy
31. Management of oncologic emergencies
32. Supportive care of patients with cancer
33. Evaluation, investigations, and management of late effects of childhood cancer
34. Psychosocial factors impacting children with cancer and their families
35. Pediatric blood banking principles and transfusion medicine practices
Jeffrey M. Lipton, MD, PhD is the Chief of Hematology/Oncology and Stem Cell Transplantation at the Steven and Alexandra Cohen Children’s Medical Center of New York and Center Head, Patient Oriented Research, The Feinstein Institute for Medical Research. He is Professor, Elmezzi Graduate School of Molecular Medicine, The Feinstein Institute for Medical Research and Professor of Pediatrics and Molecular Medicine at the Hofstra North Shore – LIJ School of Medicine. He holds a B.A. from Queens College, City University of New York, a Ph.D in Chemistry from Syracuse University and an M.D. degree, magna cum laude, from Saint Louis University Medical School. He did his Pediatric residency training at the Children’s Hospital, Boston, MA and his Pediatric Hematology/Oncology fellowship training at the Children’s Hospital and the Sidney Farber Cancer Institute (now DFCI) in Boston. Dr. Lipton is a Past-President of the Ame
- Designed to be easily readable and highly practical with over 400 illustrative tables, along with color diagrams and figures
- New chapter on Pediatric Vascular Anomalies
- New content on ‘blood avoidance’ programs to honor religious preferences
- Discussions of new drugs and immunological therapies for cancers, along with discussions of increasing use of cytokine stimulants for hematologic disorders
- Includes practical genetic evaluations providing a deeper understanding and advances in management of bone marrow failure diseases
Date de parution : 11-2021
Ouvrage de 834 p.
21.5x27.6 cm
Thèmes de Lanzkowsky's Manual of Pediatric Hematology and Oncology :
Mots-clés :
?ABO isoimmunization; AILD; AML; APML; Acquired aplastic anemia; Acute lymphoblastic leukemia; Acute myeloid leukemia; Acute promyelocytic leukemia; Alteration in mental status; Amegakaryocytic thrombocytopenia (AMT); Anaplastic large-cell lymphoma; And intracameral chemotherapy; Anemia; Anemia of prematurity; Antiemetics; Array CGH and SNV; Arteriovenous malformation; Astrocytoma; Basophils; Bereavement; Biology; Bleeding; Blood banking; Blood donation; Blood groups; Blood products; Bone cancer; Bone marrow dysfunction; Bone marrow failure; Bone tumors; Bowel obstruction; Brainstem glioma; Burkitt lymphoma; CML; CXR; Cardiomyopathy; Castleman disease; Catheter obstruction and immunization; Cerebrovascular accident; Chelation therapy; Chemotherapy; Childhood leukemia; Chondrosarcoma; Choriocarcinoma; Chronic health conditions; Classification; Clear cell sarcoma; Clinical manifestations; Coagulation; Cobalamin deficiency; Cold antibodies; Colony-stimulating factors; Complex lymphatic anomaly; Congenital dyserythropoietic anemia (CDA); Congenital erythrocytosis; Congenital mesoblastic nephroma and nephroblastomatosis; Constipation; Coombs’ test; Coping; Craniopharyngioma; Cytokine release syndrome; Diagnosis; Diamond Blackfan anemia (DBA); Direct antiglobulin test (DAT); Down syndrome and JMML; Dysgerminoma; Dyskeratosis congenita (DC); EBV; Embryonal carcinoma; Encephalopathy; End-of-life; Eosinophils; Ependymoma; Epidemiology; Epstein–Barr virus (EBV); Erdheim–Chester disease; Erythrocytosis; Ewing sarcoma family of tumors; Extravascular hemolysis; FISH; FLT3; Fanconi anemia (FA); Folate deficiency; GATA1; GVHD; Gastritis; Genetherapy; Genetic counseling; Germ cell tumor; Germinoma; Giant cell tumor of bone; HSCT and autoimmune lymphoproliferative syndrome (ALPS); Hemangioma; Hemoglobinuria; Hemolysis; Hemolytic anemia; Hemophagocytic lymphohistiocytosis; Hemophilia; Hepatoblastoma; Hepatocellular carcinoma